(Q82846505)

English

Omalizumab reduces corticosteroid use in patients with severe allergic asthma: real-life experience in Israel

scientific article published on 07 December 2011

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

title

Omalizumab reduces corticosteroid use in patients with severe allergic asthma: real-life experience in Israel (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1

Menachem Rottem

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

publication date

7 December 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

volume

49

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

page(s)

78-82

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

Identifiers

DOI

10.3109/02770903.2011.637598

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

PubMed publication ID

22149205

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22149205

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149205%20AND%20SRC:MED&resulttype=core&format=json

(Q82846505)

Omalizumab reduces corticosteroid use in patients with severe allergic asthma: real-life experience in Israel

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)